(Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological or neurological ...

Artelo Biosciences Inc. (NASDAQ:ARTL) is one of the best-performing NASDAQ stocks according to analysts. On July 7, Artelo Biosciences announced positive preclinical efficacy data for its drug ...

Tetramethylpyrazine nitrone was safe for ALS patients in a phase II trial. The investigational agent did not outperform placebo on the primary efficacy outcome. However, the treatment showed ...

Acta Pharmacologica Sinica - Tetramethylpyrazine suppresses HIF-1α, TNF-α, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats.